Top Medical News

Shifting the Paradigm: Earlier Use of On-Demand Therapy for Treating OFF Time in Parkinson Disease

August 15, 2022

By Daniel E. Kremens, MD, JD

Despite the availability of medications to relieve OFF episodes in Parkinson disease, widespread adoption of on-demand therapies has been less-than-ideal, marking the need to shift the treatment paradigm in PD.

This Week on NeurologyLive® — August 15, 2022

August 15, 2022

By NeurologyLive® Staff

Here's some of what is coming soon to NeurologyLive® this week.

Bayesian Approach Helps Integrate Adults MS Trial Data to Children, Providing Clarity on Efficacy of Treatments

August 14, 2022

By Marco Meglio

After failing to show statistical significance in a cohort of children, teriflunomide, the disease-modifying medication observed in the analysis, had compelling evidence to suggest it was efficacious in that age group following the Bayesian approach to analysis.

NeurologyLive® Brain Games: August 14, 2022

August 14, 2022

By Matt Hoffman

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is multiple sclerosis.

Raising the Awareness of Severe Preeclampsia and Recognizing Potential Long-Term Impacts

August 13, 2022

By Marco Meglio

Vesna Garovic, MD, PhD, chair of the nephrology division at Mayo Clinic, discussed the appropriate reaction to data suggesting late-life elevated inflammation and neurovascular damage from severe preeclampsia.

Featured

Mind Moments Podcast

Click here to listen to Mind Moments™, a podcast from NeurologyLive® that brings you exclusive interviews with expert neurologists and clinicians.

NeuroVoices

Click here to read NeurologyLive®'s NeuroVoices series of in-depth, exclusive conversations with a variety of experts in the care and management of patients with neurologic diseases about topics in clinical care and therapeutic development.

Coverage of the Advanced Therapeutics in Movement and Related Disorders Congress

Get the latest data and clinical news updates, as well as interviews with experts, straight from the conference floor.

Gold Standard Centers

Click here to check out the latest deep dive into examples of institutional success in medicine with our Gold Standard Centers feature series.

Brain Games

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics.

EEGTalk

EEGTalk is a series dedicated to teaching EEG reading skills in neurology in a way that is both digestible and fun, hosted by Fábio A. Nascimento, MD, and Brandon Westover MD, PhD. Click here to watch.

Latest Videos

Peers & Perspectives: The Induction vs Escalation Approach to MS and the TREAT-MS Trial

Novel Oral Treatment Selection in RRMS

Comparing Reactive Microglia and Astrocytes in Secondary Progressive Multiple Sclerosis

Using Virtual Reality to Identify Early Signs of Parkinson Disease: Jay Alberts, PhD

Changes in Vocation as Early Signs for Alzheimer Disease, Cognitive Issues: Alvaro Pascual-Leone, MD, PhD

Stigma Adds to Depressive Symptoms in Epilepsy, Parkinson Disease and Diabetes Show Increased Neuroaxonal Damage, ICER Publishes Report on ALS Treatments

What Proactive Semantic Interference and Persistent PSI Can Reveal About Cognitive Status: Rosie Curiel, PsyD

Understanding the Cognitive Risks With Preeclampsia and Raising Awareness: Vesna Garovic, MD, PhD

Realistic Views for Developing APOE-Targeted Gene Therapies for Alzheimer Disease: Yann Le Guen, PhD

Redefining, Simplifying the Complexities of Alzheimer Disease and Amyloid Cascade: Ralph Nixon, MD, PhD

Using Functional Connectivity and the Default Network to Uncover Sex-Based Differences: Jessica Caldwell, PhD

The Wide-Reaching Impact of Multiple Sclerosis DMT Wastes: Darin T. Okuda, MD; Karin Cook

Recognizing Lysosomal Autophagy as a Realistic Target for Alzheimer Disease: Ralph Nixon, MD, PhD

Most Recent

Emerging Tools for Early Detection of Alzheimer Disease

August 13, 2022

Article

The field of Alzheimer disease has entered a new era of earlier detection, creating an opportunity to redefine treatment and the clinical care of patients.

NeurologyLive® Friday 5 — August 12, 2022

August 12, 2022

Article

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending August 12, 2022.

Two Patient Deaths Reported With Zolgensma Administration in SMA

August 12, 2022

Article

The deaths, occurring shortly after treatment infusion, were because of acute liver injury, which is a known risk associated with the Novartis gene therapy.

Trends in Stroke Incidence for Younger Ages Prompt Need to Reexamine Causes, Prevention Methods

August 12, 2022

Article

When combing all 26 studies irrespective of methods, the lowest age-specific divergence in incidence was seen in 3 Southern European studies, and the most pronounced divergence in North American studies.

Episode 70: Raising Awareness of Acute Flaccid Myelitis

August 12, 2022

Podcast

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Olwen C. Murphy, MBBCh; and Matthew R. Vogt, MD, PhD.

Tools and Resources for the Management of MS

August 11, 2022

Video

Drs Jeffrey Dunn and Regina Berkovich review available tools and resources for the care of patients with multiple sclerosis, focusing on specific symptoms.

The Benefits of Collaborative Care for Patients With MS

August 11, 2022

Video

Experts in neurology explore the benefits of a collaborative care approach for patients with multiple sclerosis.

Family Planning and Vaccination Considerations for Patients With MS

August 11, 2022

Video

Regina Berkovich, MD, PhD, shares her approach on the initiation and cessation of treatment for patients with multiple sclerosis who are considering family planning and vaccinations.

Overlap Observed Between Perceived Stress, Felt Stigma, and Depressive Symptoms in Epilepsy

August 11, 2022

Article

When each variable was entered into the first step of hierarchical linear regression analysis, perceived stress explained more than 40% of the variance in depressive symptoms, followed by felt stigma, at about 20%.

Despite Large-Scale Efforts, Inverse Association Between Smoking and Parkinson Disease Remain Unelucidated

August 10, 2022

Article

Valine at position 11, the most significantly associated amino acid, was found in 26% of controls and 22% of individuals with Parkinson disease.

Latest SAP Content

Shifting the Paradigm: Earlier Use of On-Demand Therapy for Treating OFF Time in Parkinson Disease

Using Virtual Reality to Identify Early Signs of Parkinson Disease: Jay Alberts, PhD

Raising the Awareness of Severe Preeclampsia and Recognizing Potential Long-Term Impacts

What Proactive Semantic Interference and Persistent PSI Can Reveal About Cognitive Status: Rosie Curiel, PsyD

View More SAP Content